Gland Pharma Limited IPO (Gland Pharma IPO) Detail

0
783
amazon

Gland Pharma Limited IPO (Gland Pharma IPO) Detail

ABOUT THE COMPANY:

Gland Pharma Limited is Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets.Company  operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

 

 

Gland Pharma Limited
Gland Pharma Limited IPO

Gland Pharma has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities.

Company has increased our manufacturing capacities from 670 million units per annum in

Fiscal 2018 to 755 million as of March 31, 2020 and are expanding our manufacturing footprint in order to increase our product development and manufacturing capabilities.

Revenue from operations based on the Customer:

GLAND PHARMA
GGLAND PHARMA REVENUE

PROMOTERS OF GLAND PHARMA LIMITED:

  • Mr. Yiu Kwan Stanley Lau  Chairman and Independent Director
  • Mr. Srinivas Sadu MD and CEO

TOP SHAREHOLDERS OF GLAND PHARMA LIMITED:

GLAND PHARMA LIMITED
TOP SHARE HOLDERS OF GLAND PHARMA LIMITED

Financials of the Gland Pharma Limited

(in Crores) FY 18 FY 19 FY 20 30th June 2020
Revenue 1671.6 2129.7 2772.4 916.2
Net Profit 320.5 451.6 767.6 313.5

  • Objects of the ipo:

The net proceeds from the IPO will be used for the following purposes:

  • Funding incremental working capital requirements of our Company;
  • Funding capital expenditure requirements of our Company.
  • General corporate purposes.

Gland Pharma Limited IPO Details:

IPO Date Nov 9, 2020 – Nov 11, 2020
Issue Type Book Built Issue IPO
Issue Size 43,196,968 Eq Shares of ₹1
(aggregating up to ₹6,479.55 Cr)
Fresh Issue 8,333,333 Eq Shares of ₹1
(aggregating up to ₹1,250.00 Cr)
Offer for Sale 34,863,635 Eq Shares of ₹1
(aggregating up to ₹5,229.55 Cr)
Face Value ₹1 per equity share
IPO Price ₹1490 to ₹1500 per equity share
Market Lot 10 Shares
Min Order Quantity 10 Shares
Listing At BSE, NSE

Gland PharmaLimited Size and Price (Retail)

Application Lots Shares Amount (Cut-off)
Minimum 1 10 ₹15,000
Maximum 13 130 ₹195,000

 

Check IPO Allotment Status:click below

Gland Pharma Limited IPO Allotment 

Company Contact Info:

Gland Pharma Limited
Sy. No. 143 – 148, 150 and 151
Near Gandi Maisamma ‘X’ Roads
D.P. Pally, Dundigal, Dundigal – Gandi Maisamma (M)
Medchal-Malkajgiri District
Hyderabad 500 043
Telangana, India
Tel: +91 40 3051 0999
E-mail: investors@glandpharma.com

 

IPO Registrar Info:
Link Intime India Private Limited
C-101, 1st Floor
247 Park Lal Bahadur Shastri Marg
Vikhroli (West) Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
Investor e-mail: glandpharma.ipo@linkintime.co.in
Website: www.linkintime.co.in

Gland PharmaLimited IPO Lead Managers:

  • Citigroup Global Markets India Private Limited
  • Haitong Securities India Private Limited
  • Kotak Mahindra Capital Company Limited
  • Nomura Financial Advisory And Securities (India) Pvt Ltd

YOU TUBE VIDEO:

LEAVE A REPLY

Please enter your comment!
Please enter your name here